|
DK273689A
(da)
*
|
1988-06-06 |
1989-12-07 |
Sanofi Sa |
4-amino-3-carboxyquinoliner og -naphthyridiner, fremgangsmaade til deres fremstilling og anvendelse deraf i laegemidler
|
|
US6334997B1
(en)
|
1994-03-25 |
2002-01-01 |
Isotechnika, Inc. |
Method of using deuterated calcium channel blockers
|
|
KR100477070B1
(ko)
|
1994-03-25 |
2006-04-21 |
이소테크니카 인코포레이티드 |
중수소화작용에의한의약품의효능강화법
|
|
US5543534A
(en)
|
1994-12-29 |
1996-08-06 |
Allergan |
Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity
|
|
US6458373B1
(en)
|
1997-01-07 |
2002-10-01 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
|
US6699849B1
(en)
|
1998-02-23 |
2004-03-02 |
Cyclops, Ehf. |
Cyclodextrin complexes of benzodiazepines
|
|
US6875619B2
(en)
|
1999-11-12 |
2005-04-05 |
Motorola, Inc. |
Microfluidic devices comprising biochannels
|
|
US20050009101A1
(en)
|
2001-05-17 |
2005-01-13 |
Motorola, Inc. |
Microfluidic devices comprising biochannels
|
|
ATE530520T1
(de)
|
2001-08-10 |
2011-11-15 |
Shionogi & Co |
Antivirales mittel
|
|
AR037641A1
(es)
|
2001-12-05 |
2004-11-17 |
Tularik Inc |
Moduladores de inflamacion
|
|
CN1688291A
(zh)
|
2002-02-01 |
2005-10-26 |
辉瑞产品公司 |
含有固体药物分散体的即刻释放剂型
|
|
ES2387803T3
(es)
|
2003-01-08 |
2012-10-02 |
Novartis Vaccines And Diagnostics, Inc. |
Agentes antibacterianos
|
|
TW200510425A
(en)
|
2003-08-13 |
2005-03-16 |
Japan Tobacco Inc |
Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor
|
|
TW200526635A
(en)
|
2003-12-22 |
2005-08-16 |
Shionogi & Co |
Hydroxypyrimidinone derivative having HIV integrase inhibitory activity
|
|
WO2005110399A2
(en)
|
2004-04-29 |
2005-11-24 |
The Regents Of The University Of California |
Zinc-binding groups for metalloprotein inhibitors
|
|
WO2006028523A2
(en)
|
2004-04-29 |
2006-03-16 |
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN DIEGO USDC Technology Transfer Office |
Hydroxypyridinone, hydroxypyridinethione, pyrone, and thiopyrone metalloprotein inhibitors
|
|
DE102004021779A1
(de)
*
|
2004-04-30 |
2005-11-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
|
|
CN101528711A
(zh)
|
2006-08-31 |
2009-09-09 |
先灵公司 |
可用作抗细菌剂的乙内酰脲衍生物
|
|
EA200970349A1
(ru)
|
2006-10-05 |
2010-02-26 |
Янссен Фармацевтика Н.В. |
Ингибиторы металлопротеазы гетероциклического происхождения
|
|
CA2691987C
(en)
|
2007-06-12 |
2016-08-16 |
Achaogen, Inc. |
Antibacterial agents
|
|
US8871728B2
(en)
*
|
2007-06-29 |
2014-10-28 |
Georgia Tech Research Corporation |
Non-peptide macrocyclic histone deacetylese (HDAC) inhibitors and methods of making and using thereof
|
|
WO2010059838A2
(en)
|
2008-11-20 |
2010-05-27 |
Decode Genetics Ehf |
Pde4 inhibitors selective for the long form of pde4 for treating inflammation and avoiding side effects
|
|
IT1392249B1
(it)
|
2008-11-28 |
2012-02-22 |
Univ Degli Studi Urbino |
Derivati di [(3-idrossi-4-piron-2-il)metil]-amina e loro uso come farmaci anti-neoplastici
|
|
WO2010100475A1
(en)
|
2009-03-02 |
2010-09-10 |
Astrazeneca Ab |
Hydroxamic acid derivatives as gram-negative antibacterial agents
|
|
WO2012151567A1
(en)
*
|
2011-05-05 |
2012-11-08 |
St. Jude Children's Research Hospital |
Pyrimidinone compounds and methods for preventing and treating influenza
|
|
WO2012177635A1
(en)
|
2011-06-19 |
2012-12-27 |
Viamet Pharmaceuticals, Inc. |
Metalloenzyme inhibitor compounds
|
|
EP2847174B1
(en)
|
2012-04-03 |
2017-05-17 |
Bristol-Myers Squibb Company |
Pyrimidinone carboxamides as inhibitors of endothelial lipase
|
|
US10130714B2
(en)
|
2012-04-14 |
2018-11-20 |
Academia Sinica |
Enhanced anti-influenza agents conjugated with anti-inflammatory activity
|
|
HK1211289A1
(en)
*
|
2012-08-06 |
2016-05-20 |
Savira Pharmaceuticals Gmbh |
Dihydroxypyrimidine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease
|
|
AU2014209107B2
(en)
|
2013-01-28 |
2018-04-12 |
Viamet Pharmaceuticals (NC), Inc. |
Metalloenzyme inhibitor compounds
|
|
WO2014160649A1
(en)
*
|
2013-03-29 |
2014-10-02 |
Novartis Ag |
Hydroxamic acid derivatives as lpxc inhibitors for the treatment of bacterial infections
|
|
AU2014306451B2
(en)
*
|
2013-08-16 |
2019-01-17 |
Duke University |
Substituted hydroxamic acid compounds
|
|
WO2015085238A1
(en)
|
2013-12-05 |
2015-06-11 |
The Regents Of The University Of California, A California Corporation |
Inhibitors of lpxc
|
|
US9988373B2
(en)
|
2013-12-26 |
2018-06-05 |
Shionogi & Co., Ltd. |
Nitrogen-containing six-membered cyclic derivatives and pharmaceutical composition comprising the same
|
|
CA2960949A1
(en)
|
2014-09-12 |
2016-03-17 |
Tatsuya Honda |
Novel pharmaceutical composition containing hydroxamic acid derivative or salt thereof
|
|
HUE047225T2
(hu)
|
2014-12-16 |
2020-04-28 |
Novartis Ag |
LpxC inhibitor izoxazol hidroxámsav-vegyületek
|
|
CN105777464B
(zh)
|
2014-12-26 |
2020-09-29 |
中国科学院上海药物研究所 |
异羟肟酸衍生物及其制备方法和应用
|
|
US10611747B2
(en)
|
2015-11-09 |
2020-04-07 |
Forge Therapeutics, Inc. |
Pyrone based compounds for treating bacterial infections
|
|
EP3374350B1
(en)
|
2015-11-09 |
2022-01-05 |
Forge Therapeutics, Inc. |
Hydroxypyridinone and hydroxypyrimidinone based compounds for treating bacterial infections
|
|
EP3190103A1
(en)
*
|
2016-01-08 |
2017-07-12 |
Rijksuniversiteit Groningen |
Inhibitors of the pd-1/pd-l1 protein/protein interaction
|
|
US10889556B2
(en)
|
2016-03-08 |
2021-01-12 |
The Regents Of The University Of California |
Compositions and methods for inhibiting influenza RNA polymerase PA endonuclease
|
|
US11034650B2
(en)
*
|
2016-12-23 |
2021-06-15 |
Intervet Inc. |
Compounds useful for treating a Mannheimia haemolytica or Histophilus somni infection
|
|
US20200062789A1
(en)
|
2017-01-31 |
2020-02-27 |
Fujifilm Toyama Chemical Co., Ltd. |
Hydroxamic acid prodrug compound or salt thereof, lyophilized formulation, lpxc inhibitor, and antibacterial agent
|
|
EP3621962A4
(en)
|
2017-05-10 |
2020-12-09 |
Forge Therapeutics, Inc. |
ANTIBACTERIAL COMPOUNDS
|
|
WO2018208987A2
(en)
|
2017-05-10 |
2018-11-15 |
Forge Therapeutics, Inc. |
Antibacterial compounds
|
|
WO2018216822A1
(en)
|
2017-05-25 |
2018-11-29 |
Taisho Pharmaceutical Co., Ltd. |
Novel imidazole derivatives
|
|
WO2019086452A1
(en)
*
|
2017-10-31 |
2019-05-09 |
Idorsia Pharmaceuticals Ltd |
Antibacterial heteroaromatic compounds
|
|
KR102868718B1
(ko)
|
2018-02-10 |
2025-10-14 |
케이비피 바이오사이언시즈 씨오., 엘티디. |
항생제로서 작용하는 화합물
|
|
WO2020061375A1
(en)
|
2018-09-20 |
2020-03-26 |
Forge Therapeutics, Inc. |
Antibacterial compounds
|
|
US20220081421A1
(en)
|
2018-11-14 |
2022-03-17 |
Forge Therapeutics, Inc. |
Antibacterial compounds
|
|
WO2021195260A1
(en)
|
2020-03-25 |
2021-09-30 |
Forge Therapeutics, Inc. |
Lpxc inhibitor and methods of making
|
|
WO2021195258A1
(en)
|
2020-03-25 |
2021-09-30 |
Forge Therapeutics, Inc. |
Lpxc inhibitor, formulations, and uses thereof
|
|
WO2022086920A1
(en)
|
2020-10-20 |
2022-04-28 |
Blacksmith Medicines, Inc. |
Glutaminyl-peptide cyclotransferase like (qpctl) protein inhibitors and uses thereof
|
|
AR124839A1
(es)
|
2021-02-11 |
2023-05-10 |
Forge Therapeutics Inc |
Compuestos antibacterianos
|
|
EP4291550A4
(en)
*
|
2021-02-11 |
2025-01-22 |
Blacksmith Medicines, Inc. |
Antibacterial compounds
|
|
AR127139A1
(es)
*
|
2021-09-28 |
2023-12-20 |
Forge Therapeutics Inc |
Inhibidores de lpxc y usos de estos
|
|
EP4568955A4
(en)
|
2022-08-10 |
2026-08-12 |
Blacksmith Medicines Inc |
ANTIBACTERIAL COMPOUNDS
|
|
WO2024036170A1
(en)
|
2022-08-10 |
2024-02-15 |
Blacksmith Medicines, Inc. |
Antibacterial compounds
|